Integrative Analysis of the Role of TP53 in Human Pan-Cancer.
Tingting LiuJin DuXiangshu ChengJianshe WeiPublished in: Current issues in molecular biology (2023)
Tumor protein P53 ( TP53 ) is an important tumor suppressor gene in humans. Under normal circumstances, TP53 can help repair mutated genes, or promote the death of cells with severe gene mutations (specifically, TP53 prevents cells from arrest in the G1/S phase when deoxyribonucleic acid (DNA) is damaged and promotes apoptosis if not repaired), and prevents normal cells from becoming malignant cells. TP53 mutations affect its tumor suppressor function, leading to the development of malignant tumors. In this study, using a public database, we explored the pan-cancer expression of TP53 , its impact on patient survival and prognosis, the types of gene mutations, its correlation with immunity, and its regulation of other transcription factors and micro RNA (miRNA). The docking sites of therapeutic drugs and key amino acid sites of action provide a basis for future targeted therapies. TP53 has important biological functions in the human body. This study provides a theoretical basis for clinical TP53 gene therapy.
Keyphrases
- cell cycle arrest
- induced apoptosis
- endothelial cells
- gene therapy
- amino acid
- cell death
- papillary thyroid
- oxidative stress
- transcription factor
- healthcare
- genome wide
- squamous cell carcinoma
- poor prognosis
- mental health
- squamous cell
- emergency department
- early onset
- mouse model
- cell proliferation
- case report
- young adults
- single molecule
- current status
- cell free
- free survival
- molecular dynamics simulations
- dna methylation
- drug induced